LobbyingChartspan lobbying by quarter
Chartspan's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
Chartspan
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$0 · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Baker Donelson Bearman Caldwell & Berkowitz | $0 | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER SUMMA | Former SF Investigative Counsel (detailed from CMS) | Q2 2026 |
| ROBERT GARDNER | Legislative Staff for Minority Leader Schumer | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 04/20for Q1 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 01/14for Q4 2025 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 25/10/17for Q3 2025 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 25/07/09for Q2 2025 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 25/04/16for Q1 2025 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 25/01/10for Q4 2024 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 24/10/18for Q3 2024 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 24/07/19for Q2 2024 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 24/04/17for Q1 2024 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 24/01/22for Q4 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 24/01/22for Q4 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 23/10/30for Q3 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 23/10/18for Q3 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 23/07/18for Q2 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 23/04/18for Q1 2023 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |
| 23/01/18for Q4 2022 | Baker Donelson Bearman Caldwell & Berkowitz | Under $5,000 |